Crocker Gary L's Form 4 filing
Merrimack Pharmaceuticals Inc (MACK) · filed May 16, 2022
- Accession no.
- 0000899243-22-018126
- Filed
- May 16, 2022
- Trade date
- May 12-13, 2022
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 2 non-derivative transactions and 0 derivative transactions. Open-market purchases total $12.5K. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Crocker Gary LCIK 0001094201 | Director, Officer (See Remarks) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| May 12, 2022 | Common Stock | PPurchaseAcquired | +2,471 | $5.04 | +$12,453.84 | 117,809 | Indirect | |
| May 13, 2022 | Common Stock | PPurchaseAcquired | +3 | $4.90 | +$14.7 | 117,812 | Indirect |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.